Discover Tenders by Antiretroviral Drugs Sector

Find the most relevant tenders for Antiretroviral Drugs. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Antiretroviral Drugs tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Antiretroviral Drugs tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Open House Drug Discount Agreements Omalizumab Atc R03Dx05

Deadline: 05 Feb 2026

Germany

Ref. No.: 3881303

EMD:Ref Document

Bid Value: Ref Document

139 Days Left

Open House Drug Discount Agreements Multienzymes Lipase Protease Etc Atc A09Aa02

Deadline: 05 Feb 2026

Germany

Ref. No.: 3881117

EMD:Ref Document

Bid Value: Ref Document

139 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Estriol Exclusively Vcr Atc G03Cd01 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3881044

EMD:Ref Document

Bid Value: Ref Document

139 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Rivaroxaban Atc B01Af01 For The Period April 1St 2024 March 31St 2025 Plus Extension Option 1X12 Months

Deadline: 05 Feb 2026

Germany

Ref. No.: 3879402

EMD:Ref Document

Bid Value: Ref Document

139 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Filgrastim Atc L03Aa02 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3878300

EMD:Ref Document

Bid Value: Ref Document

139 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Chlorthalidone Atc Code C03Ba04

Deadline: 25 Jan 2026

Germany

Ref. No.: 3878107

EMD:Ref Document

Bid Value: Ref Document

128 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Aclidinium Bromide Atc Code R03Bb05

Deadline: 25 Jan 2026

Germany

Ref. No.: 3877960

EMD:Ref Document

Bid Value: Ref Document

128 Days Left

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Bimekizumab

Deadline: 10 Nov 2025

Germany

Ref. No.: 3691055

EMD:Ref Document

Bid Value: Ref Document

52 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Budesonide Atc A07Ea06 For The Period March 1St 2024 February 28Th 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jan 2026

Germany

Ref. No.: 3266894

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Benazepril Hydrochlorothiazide Atc C09Ba27 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3259722

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Salmeterol Atc R03Ac12 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3259003

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Metronidazole Atc D06Bx01 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3258715

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Isosorbide Mononitrate Atc C01Da14 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3258633

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Meropenem Atc J01Dh02 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3255999

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dexketoprofen Atc M01Ae17 For The Period March 1St 2024 February 28Th 2026

Deadline: 05 Jan 2026

Germany

Ref. No.: 3255834

EMD:Ref Document

Bid Value: Ref Document

108 Days Left

Showing 42346 to 42360 of 42374 results

‹
1
2
...
2816
2817
2818
2819
2820
2821
2822
2823
2824
2825
›

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

FREE Trial plan for all new users!